Challenging Cases in Skin of Color Patients
This year at the 17th Annual Dermatology, Aesthetic & Surgical Conference (ODAC), Dr Amy McMichael presented the audience with new pearls of advice on how to approach and diagnose complex medical dermatology cases in patients with skin of color. During her session, she addressed the important need for providers to be able to recognize disease in patients of all races. The majority of the glob …
This year at the 17th Annual Dermatology, Aesthetic & Surgical Conference (ODAC), Dr Amy McMichael presented the audience with new pearls of advice on how to approach and diagnose complex medical dermatology cases in patients with skin of color. During her session, she addressed the important need for providers to be able to recognize disease in patients of all races. The majority of the glob … Continue reading "Challenging Cases in Skin of Color Patients"
Sprinkled with many clinical pearls, Dr. Candrice Heath gave us an informative, case-based lecture at the 2021 Skin of Color Update: “Skin Conditions Disproportionately Affecting Pediatric & Adolescent Patients with Skin of Color.” Dr. Heath is an Assistant Professor and Director of Pediatric Dermatology at Lewis Katz School of Medicine at Temple University and is active on social media @D … 
At the 2025 ODAC Dermatology Conference, we had the privilege of hearing from Dr. Adam Friedman, a renowned expert in dermatology and the chair of the department of dermatology at the George Washington, as he shared his expert insights into the evolving landscape of off-label treatments for challenging dermatologic conditions. Dr. Friedman addressed the complexities of managing conditions such as … 
At the 2025 ODAC Dermatology Conference, Dr. Amy McMichael, distinguished professor of dermatology at Wake Forest University School of Medicine, shared her expertise on “Management Strategies for Nonscarring Alopecias.” She focused on pattern hair loss and alopecia areata, weaving in evidence and practical pearls.
Pattern Hair Loss
Dr. McMichael discussed important management considerations … 
Ketoconazole is an imidazole antifungal that was initially FDA-approved in an oral formulation for the treatment of systemic fungal infections. While oral ketoconazole has largely fallen out of use due to safety concerns, including hepatotoxicity, endocrine dysregulation, and drug interactions, topical ketoconazole has proven to be a safe and effective treatment for superficial fungal infections. … 